Brief: Neovacs Completes Reimbursement Of Liabilities As Part Of Continuation Plan
Aug 22 (Reuters) - Neovacs SA ALNEV.PA :
* REIMBURSEMENT WITH 8 YEARS IN ADVANCE OF ALL LIABILITIES
STOPPED
AS PART OF THE CONTINUATION PLAN
* UNDER THE TERMS OF THE RULING ON THE TAKEOVER BY HBR
INVESTMENT
GROUP, THE LIABILITIES DECLARED WERE APPROXIMATELY €20.4 MILLION
* POST-AGREEMENT WITH CREDITORS, THE LIABILITIES REMAINING
TO BE
CLEARED WERE NEARLY 3.3 MEUR
Source text for Eikon: ID:nACT75967
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants